Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-21-017764

EVP, North America Commercial sold 15,548 shares at an average $10.85 ($168,631)

  • EVP, North America Commercial acquired 1,166 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

O'Grady Brendan P. · EVP, North America Commercial

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-02 Sale : show line 1 in the form −15,085 $10.85 $163,601 14,868.49 D
2021-03-03 Exercise or conversion : show line 2 in the form +1,166 16,034.49 D
2021-03-03 Sale : show line 3 in the form −463 $10.86 $5,029 15,571.49 D
Open-market sales · 15,548 sh · avg $10.85 · $168,631

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-03 Exercise or conversion : show line 4 in the form Restricted Share Units −1,166 0 D
Loading xslF345X03/doc4.xml…